Home / Glossary Term / Brief summary
Learn Investment Management with University of Geneva and Coursera. Prepay and receive a 10% discount.

Brief summary

Brief summary

Brief summary is the technical name for the detailed information that appears in ads for prescription drugs. The law requires that print ads making claims about a drug (product claim ads) include a “brief summary” with all the risks listed in the drug’s “prescribing information” and at least one FDA-approved use of the drug. The brief summary generally includes:


  • Who should not take the drug
  • When the drug should not be taken
  • Possible serious side effects of the drug and, if known, what can be done to lower the chance of having them
  • Frequently occurring, but not necessarily serious, side effects


The “brief summary” includes a lot of information, so it is usually presented on its own page of a print ad. When the “brief summary” is part of an ad directed at the consumer, the FDA encourages drug companies to use language consumers can easily understand.

[Source: FDA]

ThisWikipedia: This, in the English language, is the singular proximal demonstrative.

About Piotr Wrzosiński

Piotr Wrzosinski is a sociologist focused on digital marketing in highly regulated industries. He combines experience from top players in tobacco, financial services, and pharma with a passion to the content marketing and technology. All opinions posted are his own unless stated otherwise.
Optimization WordPress Plugins & Solutions by W3 EDGE
Heap - iOS and Web Analytics